ABBOTT INDIA
|
The Current P/S Ratio of ABBOTT INDIA is 7.83.
| Share Price | ₹25,198.4 | Apr 24,2026 |
| Market Cap | ₹53,420.6 Cr | |
| Sales-TTM | ₹6,824.1 Cr | TTM-Standalone Results |
| Price/Sales | 7.83x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ABBOTT INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹53,420.6 Cr] as on Apr 24,2026
(/) Sales [ ₹6,824.1 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 7.83x ]
Thus, for ABBOTT INDIA , the investors are currently willing to pay '7.83 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ABBOTT INDIA !
The chart below summarizes the trend in P/S Ratio of ABBOTT INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of ABBOTT INDIA
PS Ratio Performance Analysis for ABBOTT INDIA
- ABBOTT INDIA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 8.76x.
- ABBOTT INDIA 's operated at median p/e ratio of 8.77x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ABBOTT INDIA 's p/e ratio peaked in Mar2025 at 10.19x.
- ABBOTT INDIA 's p/e ratio hit its five-year low in Mar2021 of 7.39x.
How does ABBOTT INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ABBOTT INDIA | 6,824.1 | 7.83 | 53,420.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 6.84 | 388,680.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.37 | 168,817.0 |
| CIPLA LTD | 28,351.1 | 3.69 | 104,588.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 10.93 | 139,297.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.17 | 109,828.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.73 | 93,582.0 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.58 | 93,293.0 |
| LUPIN LTD | 26,150.5 | 4.01 | 104,973.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.47 | 82,113.7 |
| ALKEM LABORATORIES LTD | 14,252.7 | 4.39 | 62,517.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ABBOTT INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.47x |
| Max industry PS | 16.37x |
| Median industry PS | 4.39x |
| Average industry PS | 6.36x |
You may also like the below Video Courses